JPET xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Doods, H. N.
Right arrow Articles by van Zwieten, P. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Doods, H. N.
Right arrow Articles by van Zwieten, P. A.

Selectivity of muscarinic antagonists in radioligand and in vivo experiments for the putative M1, M2 and M3 receptors

HN Doods, MJ Mathy, D Davidesko, KJ van Charldorp, A de Jonge and PA van Zwieten

In the present study we investigated the nature of the muscarinic receptors present in the hippocampus, sympathetic ganglia, atria and salivary glands of the rat. The heterogeneity of the muscarinic receptors was examined both in vivo and in radioligand binding experiments. To study whether the receptors present in the investigated tissues are indeed distinct subtypes we determined the potencies of antagonists in both systems. It is proposed that there are three different binding sites present in hippocampal, atrial and submandibular membranes and we suggest to classify them as M1, M2 and M3, respectively. Both in vivo and in vitro pirenzepine appears to possess high affinity for M1 receptors, whereas 4-diphenylacetoxy-N- methylpiperidine methobromide and dicyclomine show high affinity for both M1 and M3 receptors. AF-DX 116 (11-2[[2-[(diethylamino)methyl]-1- piperidinyl]acetyl]-5, 11-dihydro-6H-pyrido[2,3-b][1,4]benzodiazepine-6- one) displayed high affinity for M2 receptors.

Volume 242, Issue 1, pp. 257-262, 07/01/1987
Copyright © 1987 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
G. Tanda, A. L. Ebbs, T. A. Kopajtic, L. M. Elias, B. L. Campbell, A. H. Newman, and J. L. Katz
Effects of Muscarinic M1 Receptor Blockade on Cocaine-Induced Elevations of Brain Dopamine Levels and Locomotor Behavior in Rats
J. Pharmacol. Exp. Ther., April 1, 2007; 321(1): 334 - 344.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
A. Krejci and S. Tucek
Quantitation of mRNAs for M1 to M5 Subtypes of Muscarinic Receptors in Rat Heart and Brain Cortex
Mol. Pharmacol., June 1, 2002; 61(6): 1267 - 1272.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
T. Koos and J. M. Tepper
Dual Cholinergic Control of Fast-Spiking Interneurons in the Neostriatum
J. Neurosci., January 15, 2002; 22(2): 529 - 535.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
T. REINHEIMER, T. MOHLIG, S. ZIMMERMANN, K.-D. HOHLE, and I. WESSLER
Muscarinic Control of Histamine Release from Airways . Inhibitory M1-receptors in Human Bronchi but Absence in Rat Trachea
Am. J. Respir. Crit. Care Med., August 1, 2000; 162(2): 534 - 538.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
X. M. Shao and J. L. Feldman
Acetylcholine Modulates Respiratory Pattern: Effects Mediated by M3-Like Receptors in PreBotzinger Complex Inspiratory Neurons
J Neurophysiol, March 1, 2000; 83(3): 1243 - 1252.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
P. Onali and M. C. Olianas
Identification and Characterization of Muscarinic Receptors Potentiating the Stimulation of Adenylyl Cyclase Activity by Corticotropin-Releasing Hormone in Membranes of Rat Frontal Cortex
J. Pharmacol. Exp. Ther., August 1, 1998; 286(2): 753 - 759.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
J. M. Loudon, S. M. Bromidge, F. Brown, M. S. G. Clark, J. P. Hatcher, J. Hawkins, G. J. Riley, G. Noy, and B. S. Orlek
SB 202026: A Novel Muscarinic Partial Agonist with Functional Selectivity for M1 Receptors
J. Pharmacol. Exp. Ther., December 1, 1997; 283(3): 1059 - 1068.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
S. Matsumoto
Functional Evidence of Excitatory M1 Receptors in the Rabbit Airway
J. Pharmacol. Exp. Ther., April 1, 1997; 281(1): 531 - 539.
[Abstract] [Full Text]


Home page
Circ. Res.Home page
V. K. Sharma, H. M. Colecraft, D. X. Wang, A. I. Levey, E. V. Grigorenko, H. H. Yeh, and S.-S. Sheu
Molecular and Functional Identification of m1 Muscarinic Acetylcholine Receptors in Rat Ventricular Myocytes
Circ. Res., July 1, 1996; 79(1): 86 - 93.
[Abstract] [Full Text]


Home page
HypertensionHome page
T. A. Bruning, P. C. Chang, M. G.C. Hendriks, P. Vermeij, M. Pfaffendorf, and P. A. van Zwieten
In Vivo Characterization of Muscarinic Receptor Subtypes That Mediate Vasodilatation in Patients With Essential Hypertension
Hypertension, July 1, 1995; 26(1): 70 - 77.
[Abstract] [Full Text]


Home page
ScienceHome page
M Chakraborty, D Chatterjee, S Kellokumpu, H Rasmussen, and R Baron
Cell cycle-dependent coupling of the calcitonin receptor to different G proteins
Science, March 1, 1991; 251(4997): 1078 - 1082.
[Abstract] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1987 by the American Society for Pharmacology and Experimental Therapeutics.